Placental expression of sFlt-1 and PlGF in early preeclampsia vs. early IUGR vs. age-matched healthy pregnancies

Maternal–fetal interactions, predictive markers for preeclampsia, and programming

(2015) Berthold Huppertz   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

Diagnostic Accuracy of Placental Growth Factor in Women With Suspected Preeclampsia

(2013) Lucy C. Chappell et al.   CIRCULATION

Redefining Preeclampsia Using Placenta-Derived Biomarkers

(2013) Anne Cathrine Staff et al.   HYPERTENSION

Angiogenic Factors and the Risk of Adverse Outcomes in Women With Suspected Preeclampsia

(2012) Sarosh Rana et al.   CIRCULATION

The discovery of placenta growth factor and its biological activity

(2012) Sandro De Falco   EXPERIMENTAL AND MOLECULAR MEDICINE

The sFlt-1/PlGF ratio in different types of hypertensive pregnancy disorders and its prognostic potential in preeclamptic patients

(2011) Stefan Verlohren et al.   AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY

Dysregulation of anti-angiogenic agents (sFlt-1, PLGF, and sEndoglin) in preeclampsia—a step forward but not the definitive answer

(2009) J.M. Foidart et al.   JOURNAL OF REPRODUCTIVE IMMUNOLOGY

The Global Impact of Pre-eclampsia and Eclampsia

(2009) Lelia Duley   SEMINARS IN PERINATOLOGY

Placental Origins of Preeclampsia

(2008) Berthold Huppertz   HYPERTENSION

Integrated Testing and Management in Fetal Growth Restriction

(2008) Sifa Turan et al.   SEMINARS IN PERINATOLOGY

Placental Expression of Soluble fms-Like Tyrosine Kinase 1 is Increased in Singletons and Twin Pregnancies with Intrauterine Growth Restriction

(2007) Ori Nevo et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM